SEARCH

SEARCH BY CITATION

References

  • Ahren B (2009). Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8: 369385.
  • Alexander SPH et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 14491867.
  • Arrang JM, Garbarg M, Schwartz JC (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832837.
  • Barak N, Greenway FL, Fujioka K, Aronne LJ, Kushner RF (2008). Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. Int J Obes (Lond) 32: 15591565.
  • Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J et al. (2004). Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143: 649661.
  • Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C et al. (2007). Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73: 10841096.
  • Bongers G, Sallmen T, Passani MB, Mariottini C, Wendelin D, Lozada A et al. (2007). The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J Neurochem 103: 248258.
  • Boyer DF, Fujitani Y, Gannon M, Powers AC, Stein RW, Wright CV (2006). Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression. Dev Biol 298: 616631.
  • Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102110.
  • Chiba S, Itateyama E, Sakata T, Yoshimatsu H (2009). Acute central administration of immepip, a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats. Brain Res Bull 79: 3740.
  • Clark EA, Hill SJ (1996). Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur J Pharmacol 296: 223225.
  • Clark MA, Korte A, Egan RW (1993). Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells. Agents Actions 40: 129134.
  • Clineschmidt BV, Lotti VJ (1973). Histamine: intraventricular injection suppresses ingestive behavior of the cat. Arch Int Pharmacodyn Ther 206: 288298.
  • Cnop M, Hughes SJ, Igoillo-Esteve M, Hoppa MB, Sayyed F, Laar L et al. (2009). The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53: 321330.
  • Davenas E, Rouleau A, Morisset S, Arrang JM (2008). Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors. J Pharmacol Exp Ther 326: 406413.
  • Devedjian JC, Pujol A, Cayla C, George M, Casellas A, Paris H et al. (2000). Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43: 899906.
  • Drucker DJ (2006). The biology of incretin hormones. Cell Metab 3: 153165.
  • Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H et al. (2001). Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 18.
  • Dy M, Lebel B, Schneider E (1982). Presence of histaminase in fetal calf sera. J Immunol Methods 48: 261265.
  • Erickson JD, Eiden LE, Schafer MK, Weihe E (1995). Reserpine- and tetrabenazine-sensitive transport of 3H-histamine by the neuronal isoform of the vesicular monoamine transporter. J Mol Neurosci 6: 277287.
  • Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J et al. (2007). H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 87: 473487.
  • Fukui H, Fujimoto K, Mizuguchi H, Sakamoto K, Horio Y, Takai S et al. (1994). Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun 201: 894901.
  • Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J et al. (1991). Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178: 13861392.
  • Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC et al. (1992). S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J Pharmacol Exp Ther 263: 304310.
  • Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH et al. (2006). A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3: 449461.
  • UK Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837853.
  • Haas HL, Sergeeva OA, Selbach O (2008). Histamine in the nervous system. Physiol Rev 88: 11831241.
  • Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA (2010). Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol 6: 255269.
  • Henry MB, Zheng S, Duan C, Patel B, Vassileva G, Sondey C et al. (2011). Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan. Endocrinology 152: 828835.
  • Heron A, Rouleau A, Cochois V, Pillot C, Schwartz JC, Arrang JM (2001). Expression analysis of the histamine H(3) receptor in developing rat tissues. Mech Dev 105: 167173.
  • Hussain MA, Porras DL, Rowe MH, West JR, Song WJ, Schreiber WE et al. (2006). Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Mol Cell Biol 26: 77477759.
  • Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA (2008). Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci U S A 105: 1016110166.
  • Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J et al. (2003). cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 15751580.
  • Jia F, Kato M, Dai H, Xu A, Okuda T, Sakurai E et al. (2006). Effects of histamine H3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice. Neuropharmacology 50: 404411.
  • Jorgensen EA, Knigge U, Warberg J, Kjaer A (2007). Histamine and the regulation of body weight. Neuroendocrinology 86: 210214.
  • Kidd M, Tang LH, Miu K, Lawton GP, Sandor A, Modlin IM (1996). Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. Yale J Biol Med 69: 919.
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 15771579.
  • Knigge U, Soe-Jensen P, Jorgensen H, Kjaer A, Moller M, Warberg J (1999). Stress-induced release of anterior pituitary hormones: effect of H3 receptor-mediated inhibition of histaminergic activity or posterior hypothalamic lesion. Neuroendocrinology 69: 4453.
  • Leibiger IB, Leibiger B, Berggren PO (2008). Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 28: 233251.
  • Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005). The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4: 107120.
  • Lin CC, Anseth KS (2011). Cell-cell communication mimicry with poly(ethylene glycol) hydrogels for enhancing beta-cell function. Proc Natl Acad Sci U S A 108: 63806385.
  • Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J et al. (2001). Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59: 420426.
  • Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A et al. (1999). Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 11011107.
  • Lovenberg TW, Pyati J, Chang H, Wilson SJ, Erlander MG (2000). Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293: 771778.
  • Maintz L, Novak N (2007). Histamine and histamine intolerance. Am J Clin Nutr 85: 11851196.
  • McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 15731576.
  • Malmlof K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K et al. (2005). Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond) 29: 14021412.
  • Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y et al. (1990). Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126132.
  • Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H et al. (2000). High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408: 860864.
  • Nakazaki M, Ishihara H, Kakei M, Inukai K, Asano T, Miyazaki JI et al. (1998). Repetitive mitochondrial Ca2+ signals synchronize with cytosolic Ca2+ oscillations in the pancreatic beta-cell line, MIN6. Diabetologia 41: 279286.
  • Ohtsu H (2010). Histamine synthesis and lessons learned from histidine decarboxylase deficient mice. Adv Exp Med Biol 709: 2131.
  • Ohtsu H, Watanabe T (2003). New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem Biophys Res Commun 305: 443447.
  • Okamoto H, Noto Y, Miyamoto S, Mabuchi H, Takeda R (1975). Inhibition by somatostatin of insulin release from isolated pancreatic islets. FEBS Lett 54: 103105.
  • Okuda T, Zhang D, Shao H, Okamura N, Takino N, Iwamura T et al. (2009). Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice. J Pharmacol Sci 111: 167174.
  • Renstrom E, Ding WG, Bokvist K, Rorsman P (1996). Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 17: 513522.
  • Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ et al. (2010). Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327: 217220.
  • Saisho Y, Harris PE, Butler AE, Galasso R, Gurlo T, Rizza RA et al. (2008). Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39: 543551.
  • Saltiel AR, Kahn CR (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799806.
  • Shi Y, Sheng R, Zhong T, Xu Y, Chen X, Yang D et al. (2012). Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor. PLoS ONE 7: e42185.
  • Soleimanpour SA, Crutchlow MF, Ferrari AM, Raum JC, Groff DN, Rankin MM et al. (2010). Calcineurin signaling regulates human islet β-cell survival. J Biol Chem 285: 4005040059.
  • Sun P, Jin X, Koyama T, Li S, Kitamura Y, Kawasaki H (2010). R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biol Pharm Bull 33: 5863.
  • Torrent A, Moreno-Delgado D, Gomez-Ramirez J, Rodriguez-Agudo D, Rodriguez-Caso C, Sanchez-Jimenez F et al. (2005). H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways. Mol Pharmacol 67: 195203.
  • Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M (2004). Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus–secretion coupling. Endocrinology 145: 22642272.
  • Wilson S, Chambers JK, Park JE, Ladurner A, Cronk DW, Chapman CG et al. (1996). Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. J Pharmacol Exp Ther 279: 214221.
  • Yamamoto H, Matsumoto K, Araki E, Miyamoto E (2003). New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosis. J Pharmacol Sci 93: 3034.
  • Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T (1985). High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 344: 115123.